AVEO logo

AVEO Pharmaceuticals (AVEO) Cash From Investing

Annual CFI

-$16.87 M
-$34.57 M-195.27%

December 31, 2021

Summary

Performance

1-Year Change

-195.27%

3-Year Change

-190.78%

5-Year Change

-62.14%

15-Year Change

-62.14%

AVEO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$135.25 M
AVEO annual cash flow from investing activities is currently -112.47% below its historical high of $135.25 million

3-Year Low

-$16.87 M
AVEO annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
AVEO previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
AVEO next annual earnings announcement has not yet been scheduled

OtherAVEOcash flowmetrics:

Annual CFF

$82.90 M
AVEO annual cash flow from financing activities is $82.90 million

Annual CFO

-$57.26 M
AVEO annual cash flow from operations is -$57.26 million

Annual FCF

-$57.26 M
AVEO annual free cash flow is -$57.26 million

Annual CAPEX

-
AVEO annual capital expenditures value is unknown

Quarterly CFI

$7.00 M
+$8.79 M+491.72%

September 30, 2022

Summary

Performance

3-Month Change

+491.72%

1-Year Change

+135.93%

3-Year Change

+100%

5-Year Change

+159.28%

AVEO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$58.51 M
AVEO quarterly cash flow from investing activities is currently -88.04% below its historical high of $58.51 million

3-Year Low

-$1.79 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
AVEO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
AVEO next earnings announcement has not yet been scheduled

OtherAVEOcash flowmetrics:

Quarterly CFF

$36.00 K
AVEO quarterly cash flow from financing activities is $36.00 thousand

Quarterly CFO

$194.00 K
AVEO quarterly cash flow from operations is $194.00 thousand

Quarterly FCF

$194.00 K
AVEO quarterly free cash flow is $194.00 thousand

Quarterly CAPEX

-
AVEO quarterly capital expenditures value is unknown

TTM CFI

$25.10 M
+$4.03 M+19.15%

September 30, 2022

Summary

Performance

3-Month Change

+19.15%

1-Year Change

+591.79%

3-Year Change

+240.08%

5-Year Change

+240.08%

AVEO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$167.02 M
AVEO TTM cash flow from investing activities is currently -84.97% below its historical high of $167.02 million

3-Year Low

-$16.87 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
AVEO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
AVEO next earnings announcement has not yet been scheduled

OtherAVEOcash flowmetrics:

TTM CFF

$6.12 M
AVEO TTM cash flow from financing activities is $6.12 million

TTM CFO

-$22.66 M
AVEO TTM cash flow from operations is -$22.66 million

TTM FCF

-$22.66 M
AVEO TTM free cash flow is -$22.66 million

TTM CAPEX

-
AVEO TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AVEO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-195.3%+135.9%+591.8%
3 y3 years-190.8%+100.0%+240.1%
5 y5 years-62.1%+159.3%+240.1%

AVEO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-39.3%-125.5%at high-167.2%
5 y5-year-195.3%+6.2%-75.7%-502.8%at high-215.8%
alltimeall time-112.5%+754.4%-88.0%-1330.0%-85.0%-933.1%

AVEO Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2022
-
$7.00 M(-491.7%)
$25.10 M(+19.1%)
Jun 2022
-
-$1.79 M(-115.5%)
$21.07 M(-494.3%)
Mar 2022
-
$11.52 M(+37.8%)
-$5.34 M(-68.3%)
Dec 2021
-$16.87 M(-195.3%)
$8.36 M(+181.8%)
-$16.87 M(-564.9%)
Sep 2021
-
$2.97 M(-110.5%)
$3.63 M(-236.8%)
Jun 2021
-
-$28.20 M(<-9900.0%)
-$2.65 M(-126.6%)
Mar 2021
-
$0.00(-100.0%)
$9.96 M(-43.8%)
Dec 2020
$17.70 M(-198.8%)
$28.86 M(-971.0%)
$17.70 M(-160.9%)
Sep 2020
-
-$3.31 M(-78.7%)
-$29.07 M(+12.9%)
Jun 2020
-
-$15.59 M(-301.2%)
-$25.76 M(+153.3%)
Mar 2020
-
$7.75 M(-143.2%)
-$10.17 M(-43.2%)
Dec 2019
-$17.92 M(-196.4%)
-$17.92 M(<-9900.0%)
-$17.92 M(<-9900.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2019
-
$0.00(0.0%)
$10.84 M(-41.6%)
Dec 2018
$18.58 M(-278.6%)
$0.00(0.0%)
$18.58 M(-11.6%)
Sep 2018
-
$0.00(-100.0%)
$21.02 M(+128.2%)
Jun 2018
-
$10.84 M(+40.2%)
$9.21 M(-184.4%)
Mar 2018
-
$7.74 M(+216.9%)
-$10.92 M(+5.0%)
Dec 2017
-$10.40 M(+1261.5%)
$2.44 M(-120.7%)
-$10.40 M(+290.3%)
Sep 2017
-
-$11.81 M(+27.2%)
-$2.67 M(-154.4%)
Jun 2017
-
-$9.29 M(-212.5%)
$4.90 M(-14.5%)
Mar 2017
-
$8.25 M(-18.9%)
$5.73 M(-850.5%)
Dec 2016
-$764.00 K(-87.9%)
$10.18 M(-339.9%)
-$764.00 K(-95.2%)
Sep 2016
-
-$4.24 M(-49.8%)
-$15.95 M(+12.3%)
Jun 2016
-
-$8.45 M(-581.9%)
-$14.20 M(+1407.7%)
Mar 2016
-
$1.75 M(-135.0%)
-$942.00 K(-85.1%)
Dec 2015
-$6.32 M
-$5.01 M(+101.1%)
-$6.32 M(-408.5%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$2.49 M(-151.8%)
$2.05 M(-90.6%)
Jun 2015
-
$4.81 M(-232.8%)
$21.82 M(-34.4%)
Mar 2015
-
-$3.62 M(-208.0%)
$33.27 M(-39.2%)
Dec 2014
$54.71 M(+353.3%)
$3.35 M(-80.6%)
$54.71 M(-12.9%)
Sep 2014
-
$17.28 M(+6.3%)
$62.78 M(-27.6%)
Jun 2014
-
$16.26 M(-8.8%)
$86.72 M(+66.0%)
Mar 2014
-
$17.82 M(+56.0%)
$52.25 M(+332.9%)
Dec 2013
$12.07 M(-91.1%)
$11.43 M(-72.3%)
$12.07 M(-184.5%)
Sep 2013
-
$41.22 M(-326.3%)
-$14.29 M(+302.3%)
Jun 2013
-
-$18.21 M(-18.6%)
-$3.55 M(-106.5%)
Mar 2013
-
-$22.36 M(+49.7%)
$54.38 M(-59.8%)
Dec 2012
$135.25 M(-193.9%)
-$14.94 M(-128.7%)
$135.25 M(-19.0%)
Sep 2012
-
$51.95 M(+30.8%)
$167.02 M(+113.4%)
Jun 2012
-
$39.72 M(-32.1%)
$78.28 M(-264.6%)
Mar 2012
-
$58.51 M(+247.4%)
-$47.55 M(-67.0%)
Dec 2011
-$144.10 M(+59.2%)
$16.84 M(-145.8%)
-$144.10 M(-31.1%)
Sep 2011
-
-$36.79 M(-57.3%)
-$209.10 M(+46.0%)
Jun 2011
-
-$86.10 M(+126.3%)
-$143.23 M(+30.3%)
Mar 2011
-
-$38.05 M(-21.0%)
-$109.94 M(+21.5%)
Dec 2010
-$90.51 M(-2751.0%)
-$48.16 M(-265.6%)
-$90.51 M(+235.9%)
Sep 2010
-
$29.08 M(-155.1%)
-$26.95 M(-39.9%)
Jun 2010
-
-$52.81 M(+183.7%)
-$44.85 M(+744.2%)
Mar 2010
-
-$18.61 M(-220.9%)
-$5.31 M(-255.6%)
Dec 2009
$3.41 M(-87.9%)
$15.40 M(+37.8%)
$3.41 M(-128.5%)
Sep 2009
-
$11.17 M(-184.2%)
-$11.99 M(-48.2%)
Jun 2009
-
-$13.27 M(+34.2%)
-$23.16 M(+134.2%)
Mar 2009
-
-$9.89 M
-$9.89 M
Dec 2008
$28.15 M(-170.6%)
-
-
Dec 2007
-$39.89 M
-
-

FAQ

  • What is AVEO Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals annual CFI year-on-year change?
  • What is AVEO Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals quarterly CFI year-on-year change?
  • What is AVEO Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals TTM CFI year-on-year change?

What is AVEO Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of AVEO is -$16.87 M

What is the all time high annual CFI for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high annual cash flow from investing activities is $135.25 M

What is AVEO Pharmaceuticals annual CFI year-on-year change?

Over the past year, AVEO annual cash flow from investing activities has changed by -$34.57 M (-195.27%)

What is AVEO Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of AVEO is $7.00 M

What is the all time high quarterly CFI for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high quarterly cash flow from investing activities is $58.51 M

What is AVEO Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, AVEO quarterly cash flow from investing activities has changed by +$4.03 M (+135.93%)

What is AVEO Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of AVEO is $25.10 M

What is the all time high TTM CFI for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high TTM cash flow from investing activities is $167.02 M

What is AVEO Pharmaceuticals TTM CFI year-on-year change?

Over the past year, AVEO TTM cash flow from investing activities has changed by +$21.47 M (+591.79%)